Steakhouses, spices, and an $11B lab deal

🌅 Today's Morning Call

S&P Futures 7,475.25 ▲ +5.75 (+0.08%)	Nasdaq Futures 30,125.50 ▲ +88.75 (+0.30%)	Dow Futures 52,346.00 ▲ +49.00 (+0.09%)
10Y Treasury 4.40% ▼ -0.09%	US Dollar 101.74 ▲ +0.25 (+0.25%)	Bitcoin $61,084 ▲ +$101 (+0.17%)

Good morning! Thursday is serving up a full plate before the opening bell, with earnings beats from the restaurant and consumer staples corners of the market setting a constructive tone. Futures are in the green across the board, yields are easing, and at least one mid-cap biotech name just got a very generous offer. Here's everything you need to know before the market opens.

👀 What to Watch Today

The consumer story is front and center today. Darden Restaurants (DRI) dropped its fiscal Q4 numbers, posting higher profits and sales with LongHorn Steakhouse once again carrying the brand portfolio on its back. The question heading into the open is whether the market rewards DRI for the beat or starts picking apart the guidance.

McCormick (MKC) is also in focus after beating second-quarter sales and profit estimates. The spice giant is seeing a notable lift from consumers cooking at home more frequently, a trend that has quietly been a tailwind across the packaged foods space. Watch whether that narrative helps lift peers in the sector today.

On the M&A side, Germany's Merck KGaA (MKGAF, MKKGY) announced a blockbuster $11 billion offer to acquire Bio-Techne (TECH) at $73 per share, representing a 24% premium to Wednesday's close. That deal could generate chatter across the life sciences tools and diagnostics space, so keep an eye on sector neighbors for any sympathy moves.

He Called NVIDIA at $1.10 – Now He Says, “SELL” [ad]

🌏 Overnight Recap

Overnight, energy markets were absorbing two geopolitical storylines running in opposite directions. Russia signaled it will pursue legal action if Britain moves to sell crude oil seized from a Russian-linked tanker, adding a fresh wrinkle to an already complicated European energy picture. Separately, reports emerged that Chinese state refiners are weighing a return to Iranian oil imports, though analysts are tempering expectations given competing supply options and softer domestic fuel demand inside China.

Amazon (AMZN) made headlines with a commitment to invest an additional $13 billion in India by 2030, focused on AI and cloud infrastructure expansion. That announcement lands at a time when hyperscaler capital expenditure remains a dominant narrative across the tech sector, and it reinforces the broader thesis that cloud and AI buildout spending is not slowing down.

In Europe, H&M (HNNMY) reported a Q2 profit miss tied to inventory management issues, a reminder that lean inventory strategies can cut both ways. Meanwhile, easyJet (ESYJY) rejected Castlelake's fourth takeover bid at $6.49 billion but left the door open for a higher offer, keeping the airline M&A conversation alive heading into the trading day.

Your Bank Is In Danger (From Elon) [ad]

📊 Pre-Market Movers

Bio-Techne (TECH) is the standout pre-market mover this morning, surging sharply on the news that Germany's Merck KGaA has tabled an $11 billion cash offer at $73 per share. That 24% premium is hard to argue with, and TECH shares are reflecting nearly all of it in early trading. Expect volume to spike at the open.

Darden Restaurants (TECH) is trading modestly higher pre-market after its fiscal Q4 earnings topped expectations. LongHorn Steakhouse continues to punch above its weight within the portfolio, and the print gives management a credible story to tell on the full-year outlook.

On the sportswear side, Adidas (ADDYY) is drawing attention as early World Cup data shows the brand outpacing Nike (NKE) in sales momentum during the tournament. That is a notable competitive data point heading into the back half of the year, and NKE shares may face some quiet pressure as traders absorb the headline.

Are you prepared for America’s D-Day? [ad]

🔍 Today's Watchlist

1. DRI in focus: Darden's Q4 beat sets up a key test of whether restaurant stocks can hold their gains with consumer spending still under scrutiny.
2. TECH acquisition watch: Bio-Techne's 24% premium deal from Merck KGaA could spark movement across the life sciences tools sector today.
3. MKC and consumer staples: McCormick's strong quarter adds momentum to the at-home cooking trade. Watch for sector lift in peers.
4. Treasury yields retreating: the 10-year sliding to 4.40% is worth monitoring as it could provide cover for growth and rate-sensitive names.
5. AMZN cloud narrative: the $13 billion India investment reinforces the AI infrastructure buildout theme. Track tech broadly for follow-through.

🎯 The Morning Playbook

The setup for Thursday is relatively calm but not without substance. Futures are nudging higher, yields are pulling back, and there is a decent slate of company-specific stories to trade around rather than a single macro event dominating the tape. That is generally a constructive environment for stock pickers.

The M&A angle around Bio-Techne (TECH) deserves attention beyond just the ticker itself. A 24% premium offer in the life sciences tools space suggests acquirers are still finding value in mid-cap names, and that could put a floor under some of the sector's recent underperformers. Keep a watchful eye on comparable names.

With yields easing and futures in positive territory, the path of least resistance looks higher heading into the open. But with a holiday-shortened trading week on the horizon, volumes may start to thin by afternoon. Stay disciplined, focus on the stories with real earnings catalysts, and let the tape confirm before chasing any gap-up opens.

Man Who Called NVIDIA at $1.10 Issues New Alert [ad]